Zobrazeno 1 - 9
of 9
pro vyhledávání: '"L S, Zemel"'
Autor:
A M, Huber, J E, Hicks, P A, Lachenbruch, M D, Perez, L S, Zemel, R M, Rennebohm, C A, Wallace, C B, Lindsley, M H, Passo, S H, Ballinger, S L, Bowyer, A M, Reed, P H, White, I M, Katona, F W, Miller, L G, Rider, B M, Feldman
Publikováno v:
The Journal of rheumatology. 28(5)
To examine the validity of the Childhood Health Assessment Questionnaire (CHAQ) in patients with juvenile idiopathic inflammatory myopathy (IIM).One hundred fifteen patients were enrolled in a multicenter collaborative study, during which subjects we
Autor:
D J, Lovell, C B, Lindsley, R M, Rennebohm, S H, Ballinger, S L, Bowyer, E H, Giannini, J E, Hicks, J E, Levinson, R, Mier, L M, Pachman, M H, Passo, M D, Perez, A M, Reed, K N, Schikler, M, Smith, L S, Zemel, L G, Rider
Publikováno v:
Arthritis and rheumatism. 42(10)
To develop, validate, and determine the measurement characteristics of a quantitative tool for assessing the severity of muscle involvement in children with idiopathic inflammatory myopathies.The Childhood Myositis Assessment Scale (CMAS) was develop
Autor:
L G, Rider, B M, Feldman, M D, Perez, R M, Rennebohm, C B, Lindsley, L S, Zemel, C A, Wallace, S H, Ballinger, S L, Bowyer, A M, Reed, M H, Passo, I M, Katona, F W, Miller, P A, Lachenbruch
Publikováno v:
Arthritis and rheumatism. 40(11)
To determine the reliability, content validity, and responsiveness of physician global assessments of disease activity and damage in the juvenile idiopathic inflammatory myopathies (IIM), and to investigate concordance among physician, parent, and pa
Publikováno v:
The Journal of rheumatology. 22(4)
To determine the pattern of bands present on an immunoblot (Western blot) in children with Lyme arthritis.Sera from 20 children with Lyme arthritis from an endemic area were assayed, and the results compared with those obtained in 162 control sera fr
Autor:
E D, Silverman, G D, Cawkwell, D J, Lovell, R M, Laxer, T J, Lehman, M H, Passo, L S, Zemel, E H, Giannini
Publikováno v:
The Journal of rheumatology. 21(12)
To assess the efficacy and safety of intravenous immunoglobulin (IVIG) in juvenile rheumatoid arthritis (JRA).Thirty-one children with active, refractory, systemic JRA were randomized into a multicentered, double blinded, placebo controlled trial. Pa
Autor:
L S, Zemel
Publikováno v:
The Journal of rheumatology. Supplement. 34
Autor:
E H, Giannini, E J, Brewer, N, Kuzmina, A, Shaikov, A, Maximov, I, Vorontsov, C W, Fink, A J, Newman, J T, Cassidy, L S, Zemel
Publikováno v:
The New England journal of medicine. 326(16)
The antimetabolite methotrexate has been shown in placebo-controlled trials to be effective in adults with rheumatoid arthritis. Methotrexate may also be effective in children with resistant juvenile rheumatoid arthritis, but the supporting data are
Autor:
E H, Giannini, K S, Barron, C H, Spencer, D A, Person, J, Baum, B H, Bernstein, D W, Kredich, J C, Jacobs, L S, Zemel, D, Gibbas
Publikováno v:
The Journal of rheumatology. 18(8)
Eighty-eight children with juvenile rheumatoid arthritis (JRA) who completed a double blind, randomized placebo controlled trial of oral gold were entered into an open label extension phase during which they received auranofin (AF) at a dosage of 0.1
Autor:
A. M. Huber, E. M. Dugan, P. A. Lachenbruch, B. M. Feldman, M. D. Perez, L. S. Zemel, C. B. Lindsley, R. M. Rennebohm, C. A. Wallace, M. H. Passo, A. M. Reed, S. L. Bowyer, S. H. Ballinger, F. W. Miller, L. G. Rider, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group
Publikováno v:
Rheumatology; Sep2007, Vol. 46 Issue 10, p1606-1606, 1p